SCYX Q4 2018 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena

SCYXSCYNEXIS, Inc.

$37M

Q4 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$64,000+0.0% YoY

Gross Profit

$64,000100.0% margin

Operating Income

-$9M-13734.4% margin

Net Income

$2M3034.4% margin

EPS (Diluted)

$0.39

QoQ Revenue Growth

+0.0%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$465,000

Balance Sheet

Total Assets

$53M

Total Liabilities

$22M

Stockholders' Equity

$31M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$64,000	$64,000	+0.0%
Gross Profit	$64,000	$64,000	+0.0%
Operating Income	-$9M	-$7M	-22.7%
Net Income	$2M	-$8M	+125.6%

Revenue Segments

License And Service

$100,000100%